28th July 2019
Dr Antonis Pantazis and Samantha Mason discuss the past 30 years of medical process and what the future holds for research and treatment into heart muscle diseases. This article was taken from our May edition of My Life.
20th March 2019
From 1st April 2019, the drugs pregabalin and gabapentin will be reclassified as class C controlled drugs in the UK. It is important to be aware of how these changes will affect prescribing and dispensing processes. Read more here.
5th March 2019
Swiss researchers reveal a potential link between Takotsubo cardiomyopathy and raised levels of stress hormones, such as adrenaline. Read more here.
4th March 2019
A new study has pinpointed a faulty molecular brake present in the most common form of hypertrophic cardiomyopathy (HCM) and has identified a candidate compound that restores heart muscle function in human and mouse cells. Read more about the study here.
8th January 2019
Researchers have identified two biomarkers that could help in the diagnosis of a heart condition that raises the risk of stroke. Read about the study here.
16th November 2018
New study finds that for those participants who withdrew treatment for DCM, 40% experienced a re-emergence of symptoms, after just eight weeks of withdrawal. Read on to find out more.
14th June 2018
A new study published in the Journal of the American College of Cardiology shows that men are 64 percent more likely to die from dilated cardiomyopathy (DCM) than women.
18th January 2018
PHD Researcher Jennifer Rees is looking for newly diagnosed experiences of cardiomyopathy and wants to hear from you!
18th November 2017
New research shows that screening young athletes for cardiac conditions will not predict if they are at risk of cardiac arrest.
13th November 2017
It is thought that at least 3,000 adults in the UK a year suffer from ‘broken heart syndrome’ – or takotsubo – but the true number may be even higher.
